EP4313448A1 - Matériau composite comprenant une infiltration d'argent en tant que matériau de matrice antibactérien, en particulier pour la réduction de biofilm - Google Patents
Matériau composite comprenant une infiltration d'argent en tant que matériau de matrice antibactérien, en particulier pour la réduction de biofilmInfo
- Publication number
- EP4313448A1 EP4313448A1 EP22717168.3A EP22717168A EP4313448A1 EP 4313448 A1 EP4313448 A1 EP 4313448A1 EP 22717168 A EP22717168 A EP 22717168A EP 4313448 A1 EP4313448 A1 EP 4313448A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- silver
- composite material
- matrix material
- sintered
- open
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229910052709 silver Inorganic materials 0.000 title claims abstract description 193
- 239000004332 silver Substances 0.000 title claims abstract description 189
- 239000002131 composite material Substances 0.000 title claims abstract description 141
- 239000011159 matrix material Substances 0.000 title claims abstract description 107
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 title claims description 186
- 230000000844 anti-bacterial effect Effects 0.000 title claims description 76
- 230000008595 infiltration Effects 0.000 title claims description 29
- 238000001764 infiltration Methods 0.000 title claims description 29
- 230000009467 reduction Effects 0.000 title abstract description 7
- 239000011148 porous material Substances 0.000 claims abstract description 81
- 239000007943 implant Substances 0.000 claims abstract description 44
- 229910052751 metal Inorganic materials 0.000 claims abstract description 34
- 239000002184 metal Substances 0.000 claims abstract description 34
- 238000000034 method Methods 0.000 claims abstract description 27
- 239000000919 ceramic Substances 0.000 claims abstract description 22
- 229910001092 metal group alloy Inorganic materials 0.000 claims abstract description 12
- 239000000843 powder Substances 0.000 claims description 97
- 239000000203 mixture Substances 0.000 claims description 49
- 238000000576 coating method Methods 0.000 claims description 33
- 238000005245 sintering Methods 0.000 claims description 26
- 238000004519 manufacturing process Methods 0.000 claims description 24
- 238000002844 melting Methods 0.000 claims description 22
- 230000008018 melting Effects 0.000 claims description 22
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 claims description 21
- 229910052721 tungsten Inorganic materials 0.000 claims description 20
- 239000010937 tungsten Substances 0.000 claims description 20
- 230000015572 biosynthetic process Effects 0.000 claims description 18
- 229910001220 stainless steel Inorganic materials 0.000 claims description 17
- 239000010935 stainless steel Substances 0.000 claims description 16
- 239000011248 coating agent Substances 0.000 claims description 15
- 230000007774 longterm Effects 0.000 claims description 15
- 229910045601 alloy Inorganic materials 0.000 claims description 8
- 239000000956 alloy Substances 0.000 claims description 8
- 239000004053 dental implant Substances 0.000 claims description 8
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 claims description 7
- 239000000788 chromium alloy Substances 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 6
- 230000000399 orthopedic effect Effects 0.000 claims description 6
- 229910000990 Ni alloy Inorganic materials 0.000 claims description 4
- 210000000988 bone and bone Anatomy 0.000 claims description 4
- 229910000684 Cobalt-chrome Inorganic materials 0.000 claims description 3
- 229910000914 Mn alloy Inorganic materials 0.000 claims description 3
- 229910001069 Ti alloy Inorganic materials 0.000 claims description 3
- MCMNRKCIXSYSNV-UHFFFAOYSA-N ZrO2 Inorganic materials O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 claims description 3
- KGWWEXORQXHJJQ-UHFFFAOYSA-N [Fe].[Co].[Ni] Chemical compound [Fe].[Co].[Ni] KGWWEXORQXHJJQ-UHFFFAOYSA-N 0.000 claims description 3
- SZMZREIADCOWQA-UHFFFAOYSA-N chromium cobalt nickel Chemical compound [Cr].[Co].[Ni] SZMZREIADCOWQA-UHFFFAOYSA-N 0.000 claims description 3
- BCDWXIPZSYBYCG-UHFFFAOYSA-N chromium iron manganese Chemical compound [Mn][Cr][Fe] BCDWXIPZSYBYCG-UHFFFAOYSA-N 0.000 claims description 3
- BIJOYKCOMBZXAE-UHFFFAOYSA-N chromium iron nickel Chemical compound [Cr].[Fe].[Ni] BIJOYKCOMBZXAE-UHFFFAOYSA-N 0.000 claims description 3
- 239000010952 cobalt-chrome Substances 0.000 claims description 3
- 229910000623 nickel–chromium alloy Inorganic materials 0.000 claims description 3
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 claims description 3
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 claims description 3
- 229910052715 tantalum Inorganic materials 0.000 claims description 3
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 claims description 3
- 210000000332 tooth crown Anatomy 0.000 claims description 2
- 238000004070 electrodeposition Methods 0.000 claims 1
- 230000032770 biofilm formation Effects 0.000 abstract description 16
- 230000008569 process Effects 0.000 abstract description 16
- 239000000463 material Substances 0.000 description 47
- 208000035874 Excoriation Diseases 0.000 description 42
- 238000005299 abrasion Methods 0.000 description 42
- 239000011230 binding agent Substances 0.000 description 30
- 210000000214 mouth Anatomy 0.000 description 19
- 238000000465 moulding Methods 0.000 description 18
- 230000002829 reductive effect Effects 0.000 description 18
- 210000003298 dental enamel Anatomy 0.000 description 16
- 238000011282 treatment Methods 0.000 description 15
- 238000010276 construction Methods 0.000 description 13
- 241000894006 Bacteria Species 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- 208000002925 dental caries Diseases 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 238000004140 cleaning Methods 0.000 description 8
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 7
- 239000000853 adhesive Substances 0.000 description 7
- 230000001070 adhesive effect Effects 0.000 description 7
- 238000005115 demineralization Methods 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 230000002328 demineralizing effect Effects 0.000 description 6
- 238000000151 deposition Methods 0.000 description 6
- 150000002739 metals Chemical class 0.000 description 6
- 238000010008 shearing Methods 0.000 description 6
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 5
- 241000519995 Stachys sylvatica Species 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 230000005923 long-lasting effect Effects 0.000 description 5
- 238000003825 pressing Methods 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 4
- 238000000149 argon plasma sintering Methods 0.000 description 4
- 238000001218 confocal laser scanning microscopy Methods 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000003902 lesion Effects 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 239000002105 nanoparticle Substances 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- 230000000717 retained effect Effects 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 238000010146 3D printing Methods 0.000 description 3
- 241000194019 Streptococcus mutans Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 210000004268 dentin Anatomy 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 230000003239 periodontal effect Effects 0.000 description 3
- 201000001245 periodontitis Diseases 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- -1 polytetrafluoroethylene Polymers 0.000 description 3
- 230000003449 preventive effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 230000035508 accumulation Effects 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000004873 anchoring Methods 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000010065 bacterial adhesion Effects 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 230000001680 brushing effect Effects 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 229910052804 chromium Inorganic materials 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- 238000002149 energy-dispersive X-ray emission spectroscopy Methods 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 231100000024 genotoxic Toxicity 0.000 description 2
- 230000001738 genotoxic effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 230000002427 irreversible effect Effects 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 229940127554 medical product Drugs 0.000 description 2
- 239000007769 metal material Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 230000008450 motivation Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 229910052759 nickel Inorganic materials 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 210000004261 periodontium Anatomy 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 238000005240 physical vapour deposition Methods 0.000 description 2
- 230000007406 plaque accumulation Effects 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 238000001878 scanning electron micrograph Methods 0.000 description 2
- 238000000110 selective laser sintering Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- 241000606749 Aggregatibacter actinomycetemcomitans Species 0.000 description 1
- 229910000531 Co alloy Inorganic materials 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 208000014151 Stomatognathic disease Diseases 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 208000008312 Tooth Loss Diseases 0.000 description 1
- HZEWFHLRYVTOIW-UHFFFAOYSA-N [Ti].[Ni] Chemical compound [Ti].[Ni] HZEWFHLRYVTOIW-UHFFFAOYSA-N 0.000 description 1
- QQMBHAVGDGCSGY-UHFFFAOYSA-N [Ti].[Ni].[Ag] Chemical compound [Ti].[Ni].[Ag] QQMBHAVGDGCSGY-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000001013 cariogenic effect Effects 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 208000001277 chronic periodontitis Diseases 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 239000003479 dental cement Substances 0.000 description 1
- 239000005548 dental material Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000009713 electroplating Methods 0.000 description 1
- 201000010840 enamel caries Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000004334 fluoridation Methods 0.000 description 1
- 230000009760 functional impairment Effects 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 230000000642 iatrogenic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000010309 melting process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- 231100001223 noncarcinogenic Toxicity 0.000 description 1
- 231100000065 noncytotoxic Toxicity 0.000 description 1
- 230000002020 noncytotoxic effect Effects 0.000 description 1
- 229910052574 oxide ceramic Inorganic materials 0.000 description 1
- 239000011224 oxide ceramic Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- 230000008823 permeabilization Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000002294 pubertal effect Effects 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000035806 respiratory chain Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000000565 sealant Substances 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000010972 statistical evaluation Methods 0.000 description 1
- 230000003746 surface roughness Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F3/00—Manufacture of workpieces or articles from metallic powder characterised by the manner of compacting or sintering; Apparatus specially adapted therefor ; Presses and furnaces
- B22F3/24—After-treatment of workpieces or articles
- B22F3/26—Impregnating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
- A61K6/84—Preparations for artificial teeth, for filling teeth or for capping teeth comprising metals or alloys
- A61K6/844—Noble metals
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F10/00—Additive manufacturing of workpieces or articles from metallic powder
- B22F10/20—Direct sintering or melting
- B22F10/28—Powder bed fusion, e.g. selective laser melting [SLM] or electron beam melting [EBM]
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y10/00—Processes of additive manufacturing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y70/00—Materials specially adapted for additive manufacturing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y80/00—Products made by additive manufacturing
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B41/00—After-treatment of mortars, concrete, artificial stone or ceramics; Treatment of natural stone
- C04B41/009—After-treatment of mortars, concrete, artificial stone or ceramics; Treatment of natural stone characterised by the material treated
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B41/00—After-treatment of mortars, concrete, artificial stone or ceramics; Treatment of natural stone
- C04B41/45—Coating or impregnating, e.g. injection in masonry, partial coating of green or fired ceramics, organic coating compositions for adhering together two concrete elements
- C04B41/50—Coating or impregnating, e.g. injection in masonry, partial coating of green or fired ceramics, organic coating compositions for adhering together two concrete elements with inorganic materials
- C04B41/51—Metallising, e.g. infiltration of sintered ceramic preforms with molten metal
- C04B41/5116—Ag or Au
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B41/00—After-treatment of mortars, concrete, artificial stone or ceramics; Treatment of natural stone
- C04B41/80—After-treatment of mortars, concrete, artificial stone or ceramics; Treatment of natural stone of only ceramics
- C04B41/81—Coating or impregnation
- C04B41/85—Coating or impregnation with inorganic materials
- C04B41/88—Metals
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22C—ALLOYS
- C22C1/00—Making non-ferrous alloys
- C22C1/04—Making non-ferrous alloys by powder metallurgy
- C22C1/045—Alloys based on refractory metals
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22C—ALLOYS
- C22C1/00—Making non-ferrous alloys
- C22C1/04—Making non-ferrous alloys by powder metallurgy
- C22C1/05—Mixtures of metal powder with non-metallic powder
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22C—ALLOYS
- C22C29/00—Alloys based on carbides, oxides, nitrides, borides, or silicides, e.g. cermets, or other metal compounds, e.g. oxynitrides, sulfides
- C22C29/12—Alloys based on carbides, oxides, nitrides, borides, or silicides, e.g. cermets, or other metal compounds, e.g. oxynitrides, sulfides based on oxides
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22C—ALLOYS
- C22C33/00—Making ferrous alloys
- C22C33/02—Making ferrous alloys by powder metallurgy
- C22C33/0242—Making ferrous alloys by powder metallurgy using the impregnating technique
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C8/00—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
- A61C8/0018—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools characterised by the shape
- A61C8/0037—Details of the shape
- A61C2008/0046—Textured surface, e.g. roughness, microstructure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C8/00—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
- A61C8/0012—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools characterised by the material or composition, e.g. ceramics, surface layer, metal alloy
- A61C8/0013—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools characterised by the material or composition, e.g. ceramics, surface layer, metal alloy with a surface layer, coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/38—Joints for elbows or knees
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30721—Accessories
- A61F2/30734—Modular inserts, sleeves or augments, e.g. placed on proximal part of stem for fixation purposes or wedges for bridging a bone defect
- A61F2002/30736—Augments or augmentation pieces, e.g. wedges or blocks for bridging a bone defect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/3094—Designing or manufacturing processes
- A61F2/30942—Designing or manufacturing processes for designing or making customized prostheses, e.g. using templates, CT or NMR scans, finite-element analysis or CAD-CAM techniques
- A61F2002/30962—Designing or manufacturing processes for designing or making customized prostheses, e.g. using templates, CT or NMR scans, finite-element analysis or CAD-CAM techniques using stereolithography
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B2111/00—Mortars, concrete or artificial stone or mixtures to prepare them, characterised by specific function, property or use
- C04B2111/00474—Uses not provided for elsewhere in C04B2111/00
- C04B2111/00836—Uses not provided for elsewhere in C04B2111/00 for medical or dental applications
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22C—ALLOYS
- C22C33/00—Making ferrous alloys
- C22C33/02—Making ferrous alloys by powder metallurgy
- C22C33/0257—Making ferrous alloys by powder metallurgy characterised by the range of the alloying elements
- C22C33/0278—Making ferrous alloys by powder metallurgy characterised by the range of the alloying elements with at least one alloying element having a minimum content above 5%
- C22C33/0285—Making ferrous alloys by powder metallurgy characterised by the range of the alloying elements with at least one alloying element having a minimum content above 5% with Cr, Co, or Ni having a minimum content higher than 5%
Definitions
- the present invention relates to a composite material made from an open-pore, porous, sintered matrix material and elemental silver, the elemental silver being infiltrated into the pores of the open-pore, porous, sintered matrix material, the silver content in the composite material being between 6% by weight and 30% by weight.
- % is, and the open-pored, porous, sintered matrix material consists of at least one metal, at least one metal alloy or at least one ceramic, as well as methods for producing this composite material and medical implants containing this composite material.
- the composite material is particularly suitable for reducing and avoiding biofilm formation.
- the present invention also describes an antibacterial composite material for medical implants, preferably long-term medical implants, in particular for use as bracket material in orthodontics.
- No surface coating is applied, but antibacterial silver is introduced by means of infiltration, e.g. into the pores of a metal or ceramic sinter.
- the silver does not form a closed surface, but has a sufficient long-distance effect to prevent biofilm adhesion over a large area.
- Biofilm formation in the oral environment is one of the central problems in dentistry. Microorganisms trigger caries, periodontal diseases and other dental diseases, which are the main diseases to be treated in dentistry.
- tooth decay is “a multifactorial destructive disease of hard tooth tissue, enamel and dentine. It develops with the participation of microorganisms and starts from a tooth surface that has been “decalcified” by the action of acids.”
- Biofilm formation also promotes the development of periodontitis, i.e. an inflammatory disease of the entire periodontium including the jawbone.
- Periodontitis i.e. an inflammatory disease of the entire periodontium including the jawbone.
- Adult patients in particular are affected by the attachment of Plaque on intraoral surfaces is at increased risk of periodontitis.
- chronic periodontitis can develop or worsen, which, if left untreated, can lead to loosening of the teeth due to loss of attachment and, in extreme cases, ultimately to tooth loss.
- Undesirable biofilm formation is also of immense importance in orthodontics and particularly affects the large patient group of young people in puberty, whose motivation in the field of dental care is often restrained. To make matters worse, young patients are more susceptible to gingivitis, an inflammation of the marginal gums caused by bacteria, due to pubertal hormonal changes.
- Treatment devices such as brackets, have niches that are difficult to clean due to their geometry, which can lead to demineralization of the tooth enamel in the area around the brackets if there is insufficient oral hygiene.
- the bacteria metabolize carbohydrates into organic acids and an acidic anaerobic environment is created. As a result, calcium and phosphate ions are released from the crystal lattice structure of the tooth enamel. In the long term, this decalcification of the enamel becomes visible as irreversible white spots, so-called "white spot lesions”.
- the "white spot lesions" are the initial stage of a carious lesion of the tooth. If the acidic environment persists and demineralization processes progress, the initial enamel caries leads to dentine caries.
- the aim is to counteract the favorable propagation environment for microorganisms in the mouth through improved oral hygiene or to select dental materials with reduced biofilm affinity (in each case depending on the material and its surface) or to provide the orthodontic appliances with bactericidal properties.
- a preventive approach lies in patient motivation and guidance.
- the focus here is on improving oral hygiene at home.
- the reduction of the oral biofilm is of great importance as part of the professional tooth cleaning that is to be carried out every six months.
- an increase in the acid resistance of the tooth enamel can be achieved by regular home and in-office fluoridation.
- the use of antimicrobial or fluoride-containing mouthwash solutions, which can noticeably reduce the formation of biofilms, is recommended.
- One of the aims is to effectively reduce the cariogenic bacterium Streptococcus mutans and to have an inhibitory effect on Aggregatibacter actinomycetemcomitans.
- Fixing adhesives adhesives for fixing the brackets
- fluoride nanoparticles are used. These fluoride-containing fastening materials lead to increased resistance of the Tooth hard substance against an acidic anaerobic environment and thus for less demineralization of the enamel. In the area of fluoride-containing luting composites, a tendency towards less demineralization of the enamel could be determined.
- a mechanical-chemical barrier against acid attack can be created by sealing the enamel in the immediate vicinity of the bracket.
- the seals are not very resistant to abrasion and therefore only have a temporary effect. d) Coatings of bracket appliances
- Antibacterial coatings on brackets prevent biofilm formation from the start while at the same time ensuring good biocompatibility.
- the coatings are applied over the entire surface, i.e. the antibacterial top layers have a completely closed surface, which encapsulates the base material, i.e. the actual bracket material.
- One method is to seal orthodontic appliances with polytetrafluoroethylene (PTFE) to prevent polysaccharide adhesion.
- PTFE polytetrafluoroethylene
- antibacterial coatings applied galvanically or by means of the physical vapor deposition (PVD) process are suitable.
- Chinese patent application CN 111 197 130 A discloses powdered Co-based alloys containing 1-5% by weight of silver, which are used for tooth restorations or dental prostheses.
- the dental prostheses can be produced from the powdered alloys using 3D printing (selective laser melting).
- Chinese patent CN 102 648 876 B discloses an antibacterial orthopedic dental wire made of a titanium-nickel alloy, wherein 0.1 to 20% by weight of granular silver is dispersed in the orthopedic wire.
- the mass ratio of titanium and nickel in the antibacterial orthopedic wire is 45:55-55:45.
- the wire can be made from a powdered titanium-nickel-silver mixture by melting, sintering or high-temperature synthesis.
- Feilong et al. (Materials & Design 2019, 184, 108190) report on a cobalt alloy with antibacterial properties containing 30 at.% chromium and 5 at.% silver.
- the alloy is made by sintering a powder mixture of cobalt, chromium and silver.
- silver nanoparticles are not only incorporated into luting adhesives or cements, but also used as a coating. It has been demonstrated that bacterial adhesion can be prevented on dentine coated with silver nanoparticles.
- Silver nanoparticles have a size of up to 100 nm and are therefore able to occur outside of solid and liquid solid states. They can have a cytotoxic effect by affecting the cell cycle, DNA and cell apoptosis. Above a certain concentration, silver nanoparticles have a cell and genotoxic effect on human mesenchymal stem cells character and cause DNA damage, cell death and functional impairment.
- pure silver coatings have the disadvantage of low abrasion resistance.
- a problem for superficially applied coatings within the oral cavity is the high intraoral abrasion load due to strong shearing and muscle forces of the teeth, tongue and perioral muscles as well as the attack by various liquids in the oral cavity.
- the antibacterial effect is quickly lost as a result of partial damage or extensive abrasion of the usually very thin coatings. The antibacterial protective effect is therefore not permanent.
- the object of the present invention is therefore to provide a material for an implant and an implant that prevents the formation of a biofilm or at least counteracts the formation of it while at the same time being resistant to shearing forces and abrasion in order to achieve a permanent protective effect. According to the invention, this object is achieved by the technical teaching of the independent claims. Further advantageous configurations of the invention result from the dependent claims, the description, the figures and the examples.
- the present invention thus relates to a composite material made from an open-pore, porous, sintered matrix material and elemental silver, the elemental silver being infiltrated into the pores of the open-pore, porous, sintered matrix material, the silver content in the composite material being between 6% by weight and 30% by weight.
- -% is, and the open-pore, porous, sintered matrix material consists of at least one metal, at least one metal alloy or at least one ceramic.
- open-pore, porous, sintered matrix material refers to the base material made of a metal, a metal alloy or a ceramic, which is produced in a sintering process and in whose pores the elemental silver is infiltrated.
- the matrix material itself has no antibacterial properties.
- Solid here means that a powdery starting material is pressed together to form a sinter with a specific grain size and then shaped into a solid matrix material by heat treatment.
- all metals, metal alloys and ceramics with the following properties are suitable as matrix material: a) Biocompatibility (corrosion-resistant, haemocompatible, non-cytotoxic and genotoxic, non-carcinogenic), b) abrasion resistance that is usual for dental implants, c) sinterability for the production of porous materials, d) low brittleness, ie sufficient ductility not to withstand sudden stress to break.
- Examples of preferred matrix materials are metals and metal alloys approved for implants, such as stainless steel (e.g. 316LVM®, 316L medical), Co-based alloys or CoCr materials (e.g. L605®, Phynox®, MP35N®), nickel free iron-chromium-manganese alloys such as Vasculoy®, cobalt-nickel-chromium alloys such as Duratherm®, iron-chromium-nickel alloys such as Durinox®, iron-cobalt-nickel alloys such as Durnico® and Phytime ®, titanium alloys, tantalum and tungsten as well as ceramics made of aluminum oxide or zirconium dioxide.
- stainless steel e.g. 316LVM®, 316L medical
- Co-based alloys or CoCr materials e.g. L605®, Phynox®, MP35N®
- nickel free iron-chromium-manganese alloys such as Vasculoy®
- composition of Vasculoy® (weight %)
- composition of Duratherm® 600 (in percent by weight)
- composition of Durnico® (weight %)
- Composition of Phytime® (weight %)
- Metals and metal alloys are therefore suitable as matrix material.
- examples are stainless steels, CoCr alloys, iron-chromium-manganese alloys, cobalt-nickel-chromium alloys, iron-chromium-nickel alloys, iron-cobalt-nickel alloys, titanium alloys, tantalum and tungsten, and aluminum oxide ceramics Zirconium dioxide ceramics.
- the metals, metal alloys and ceramics are suitable as materials for dental implants.
- abrasion resistance or "abrasion resistance” as used herein denotes a high resistance to abrasion, so that scraping and abrasion occur only to a small extent, which is normal in the dental field. A certain abrasion is tolerable and also unavoidable.
- An advantage according to the invention is that the silver is homogeneously distributed in the matrix material, so that even in the event of abrasion, silver repeatedly comes to the surface, which prevents the formation of a biofilm.
- Brittleness is a material property that describes the failure or fracture behavior. A brittle material can only be plastically deformed to a small extent and is therefore characterized by low ductility.
- porosity represents the ratio of the void volume to the total volume of the matrix material and is made up of the sum of the voids that are connected to each other and to the environment (open porosity) and the voids that are not interconnected. It serves as a classifying measure of the actual present cavities.
- the porosity can be represented by the following formula where V H denotes the void volume, V the total volume and V F the net volume of the solid.
- the matrix materials used here have a high open porosity; they are therefore »open-pore porous «.
- a porosity of the matrix material of less than 30%, preferably less than 20%, more preferably less than 15% has proven advantageous. With a porosity of 6% - 10%, corresponding to a silver content of 6% - 10%, the antibacterial effect is reduced and below 6% it is almost non-existent.
- silver has an antibacterial and healing effect when it comes into contact with blood or tissue.
- the antibacterial effect of silver is based on the permeabilization of the bacterial cell membrane and the formation of intracellular complexes with bacterial enzymes that are difficult to dissolve. This leads to the destruction of the bacterial respiratory chain and the inhibition of the DNA replication of the microorganisms.
- the silver must be infiltrated into the pores of the open-pore, porous, sintered matrix material, so that not only does the surface of the matrix material have an antibacterial effect, but a composite material is created which is antibacterial not only on its surface but throughout the entire material.
- a distribution of the silver in the matrix material is achieved such that per arbitrarily selected unit volume of composite material, the same mass of matrix material and the equal masses of silver are included.
- the deviations in the mass of matrix material and the mass of silver between two arbitrarily chosen volume units of the composite material are not more than 20%. Illustratively, this means the following.
- FIG. 1 shows a scanning electron micrograph of a cross section of a porous tungsten matrix material.
- the stored silver is shown in black. The distribution of the silver throughout the tungsten matrix material can be clearly seen.
- the elemental silver content in the composite material is between 6% by weight and 30% by weight, more preferably between 7% by weight and 25% by weight, more preferably between 8% by weight and 20% by weight , more preferably between 9% and 17% and most preferably between 10% and 15% by weight silver based on the composite material.
- the silver is also infiltrated into the pores of the open-pore, porous, sintered matrix material in such a way that the pores are at least partially filled with elemental silver.
- the pores of the matrix material are completely filled with elemental silver.
- Composite material as used herein means the combination of matrix material and silver, with a certain amount of elemental silver being infiltrated into the pores of the open-pored, sintered matrix material. An antibacterial composite material is thus obtained which is not only antibacterial on its surface but also at any point within the composite material. The composite material in the medical implant therefore has no antibacterial coating.
- the composite material is thus a new material made of matrix material and elemental silver distributed therein and not a matrix material with an antibacterial coating. This means that even with abrasion and even with heavy abrasion, the The antibacterial properties of the composite material are retained, since abrasion repeatedly causes silver to come to the surface of the composite material, thereby maintaining the antibacterial effect over the long term.
- the composite material according to the invention combines both properties in an ideal way. It consists of a porous matrix material with infiltrated silver as an intramatrix filler.
- the matrix material ensures stability and gives the composite material high abrasion resistance, and the infiltrated, homogeneously distributed silver ensures the antibacterial effect not only on the surface of the composite material and maintains the antibacterial effect even in the case of severe abrasion.
- the composite material is neither an alloy nor a mixed crystal of silver and the components of the matrix material.
- An alloy is a macroscopically homogeneous metallic material made up of at least two elements, at least one of which is a metal, and which together exhibit the metal-typical feature of metal bonding.
- elemental silver is infiltrated into the pores of the matrix material and at least partially fills them. There is therefore no compound in which the silver atoms are integrated into the crystal structure of the matrix material.
- the composite material according to the invention thus serves to reduce or prevent the formation and adhesion of a biofilm to the surface of the composite material.
- the composite serves to permanently reduce or prevent the formation and adhesion of a biofilm to the surface of the composite while the composite is in the body.
- the composite material according to the invention can be produced in a sintering process and subsequent silver infiltration.
- a further aspect of the present invention lies in a method for producing the composite material described herein, comprising the following steps:
- step B) sintering of the sintered blank according to step B) below the melting temperature of the matrix material to form an open-pore, porous sintered compact with a porosity of 6% to 30%;
- step D) infiltration of the open-pored porous sintered body according to step C) with elemental silver until the pores are at least partially filled with elemental silver.
- the sintering process can be carried out using a pressed sinter blank, a granular powder or a granular powder mixture of the matrix material, using laser sintering of powder layers of the matrix material, or using a 3D-printed sinter blank.
- a sintered blank is pressed from fine-grained metal or ceramic powder or from a mixture of different grain sizes of a metal or ceramic powder.
- the sintered blank usually already has the desired shape
- the sintered matrix material i.e. the sintered part, must have open porosity.
- the porosity of the sintered part must be large enough that silver can infiltrate the matrix material and then there is enough silver in the matrix material or in the composite material to ensure an antibacterial effect.
- the porosity should only be so large that as little expensive silver as possible is consumed and the abrasion resistance of the matrix material is retained or only slightly reduced.
- a porosity of the matrix material of less than 30%, preferably less than 20%, more preferably less than 15% has proven advantageous. With a porosity of 6% - 10%, corresponding to a silver content of 6% - 10%, the antibacterial effect is reduced and below 6% it is almost non-existent.
- a further aspect of the present invention lies in a method for producing the composite material described herein, comprising the following steps: A) Provision of a granular powder or a granular powder mixture of the matrix material;
- step B pressing a sintered blank from the granular powder or from the granular powder mixture of the matrix material from step A);
- step B) sintering of the sintered blank according to step B) below the melting temperature of the matrix material to form an open-pore, porous sintered compact with a porosity of 6% to 30%;
- step D) infiltration of the open-pored porous sintered body according to step C) with elemental silver until the pores are at least partially filled with elemental silver.
- the method for producing the composite material described herein comprises the following steps:
- step B pressing a sintered blank from the granular powder or from the granular powder mixture of the matrix material from step A);
- step B) sintering of the sintered blank according to step B) with or without application of pressure by heat treatment below the melting temperature of the matrix material to form an open-pore, porous sintered compact with a porosity of 6% to 30%;
- step D) infiltration of the open-pored porous sintered body according to step C) with elemental silver until the pores are at least partially filled with elemental silver.
- the porosity according to step C) is preferably between 6% and 20%, more preferably between 8% and 15% and even more preferably between 10% and
- the sintered blank is preferably already produced in the shape of the desired workpiece or molded part.
- step D) the pores of the open-pore porous sintered compact according to step C) are preferably completely filled with elemental silver.
- the composite material according to the invention can also be produced by means of laser sintering and subsequent silver infiltration:
- a more recent method is the production of the sintered parts using what is known as selective laser sintering (SLS), an additive manufacturing method to produce three-dimensional structures by sintering with a laser beam from a powdery starting material.
- SLS selective laser sintering
- a powder or a powder mixture of matrix material is applied to a construction platform in a thin layer over the entire surface.
- the component contour is gradually sintered or melted into the powder bed layer by layer by rapid lateral deflection of the laser beam in the x and y directions, according to the respective layer contour of the component.
- the beam energy of the focused laser beam is absorbed by the powder and leads to locally limited sintering of the powder particles.
- the construction platform is lowered slightly after each laser sintering/melting process and a new layer of powder is applied.
- the workpiece is thus built up layer by layer.
- the remaining powder is simply removed and some of it can be reused for the next run.
- an abrasion-resistant, open-pored porous sintered part can be produced. This method offers the advantage of being able to create almost any shape.
- the present patent application relates to a method for producing a molded part from the composite material described herein, comprising the following steps:
- step B) Application of a thin layer of the powder or the powder mixture from step A) to a construction platform;
- step B) sintering of the applied thin layer according to step B) by means of a laser
- the porosity of the molding is preferably between 6% and 20%, more preferably between 8% and 15% and even more preferably between 10% and 12%.
- step E the pores of the molding are preferably completely filled with elemental silver.
- the composite material according to the invention can also be produced using the 3D printing process (binder jetting) and subsequent silver infiltration:
- the binder jetting process creates a molded part in layers from a powdered starting material.
- the powdered starting material is bonded with a liquid binding agent (binder) at selected points of each powder layer.
- a powder or a powder mixture of matrix material is applied to a construction platform in a thin layer over the entire surface.
- the powder layer is then bonded with a binder at the points that belong to the workpiece.
- the binder is applied with a print head.
- the construction platform is lowered slightly after each binder printing process, and a new layer of powder and additional binder is applied.
- the workpiece is thus built up layer by layer.
- the binder is thermally cured and the remaining loose powder is easily removed and partially reused for the next run.
- the workpiece can then be debound by thermally driving out the binder or the binder components, with the workpiece being sintered.
- the present patent application relates to a method for producing a molded part from the composite material described herein, comprising the following steps:
- step B) Application of a thin layer of the powder or the powder mixture from step A) to a construction platform;
- step C) selectively applying a binder to the applied thin layer of step B);
- the porosity of the molding according to step D4) is preferably between 6% and 20%, more preferably between 8% and 15% and even more preferably between 10% and 12%.
- step E) the pores of the molding according to step D4) are preferably completely filled with elemental silver.
- the method for producing a molded part from the composite material described herein comprises the following steps:
- step B) Application of a thin layer of the powder or the powder mixture from step A) to a construction platform;
- step C) selectively applying a binder to the applied thin layer of step B);
- step D4 sintering the molding according to step D2) to form an open-pored porous sintered part with a porosity of 6% to 30%, and removing the binder in the process,
- step D4 infiltrating the open-pored porous sintered body according to step D4) with elemental silver until the pores are at least partially filled with elemental silver.
- the porosity of the sintered compact according to step D4) is preferably between 6% and 20%, more preferably between 8% and 15% and even more preferably between 10% and 12%.
- step E the pores of the sintered compact according to step D4) are preferably completely filled with elemental silver.
- Subsequent infiltration of the pores with elemental silver can be achieved by immersing the sintered part in a silver melt or by galvanic deposition.
- the sintered part is immersed in molten silver under negative pressure conditions and silver is thus immersed in the open-pored sintered material infiltrated.
- the negative pressure ensures that the silver penetrates and fills all pores of the sintered part.
- the matrix material would also melt if it consisted of materials having a melting point below the melting point of silver. Accordingly, in this process, materials must be selected that have a higher melting point than the melting point of silver, i.e. greater than 962 °C.
- one embodiment of the present invention relates to a method for producing the composite material described herein, comprising the following steps:
- step B producing a sintered blank from the granular powder or from the granular powder mixture of the matrix material from step A);
- step B) sintering of the sintered blank according to step B) below the melting temperature of the matrix material to form an open-pored sintered body with a porosity of 6% to 30%;
- step D1) immersing the open-pore porous sintered body according to step C) under reduced pressure conditions in molten elemental silver until the pores are filled with elemental silver;
- step D2) Removal of the sintered part according to step D1) from the liquid silver and cooling to room temperature.
- the method for producing the composite material described herein comprises the following steps:
- step B pressing a sintered blank from the granular powder or from the granular powder mixture of the matrix material from step A);
- step B) sintering of the sintered blank according to step B) with or without application of pressure by heat treatment below the melting temperature of the matrix material to form an open-pored sintered compact with a porosity of 6% to 30%;
- step D1) immersing the open-pore porous sintered body according to step C) under reduced pressure conditions in molten elemental silver until the pores are filled with elemental silver; D2) Removal of the sintered part according to step D1) from the liquid silver and cooling to room temperature.
- the porosity according to step C) is preferably between 6% and 20%, more preferably between 8% and 15% and even more preferably between 10% and 12%.
- the sintered blank is preferably already produced in the shape of the desired workpiece or molded part.
- step D1) the pores of the open-pore porous sintered compact according to step C) are preferably completely filled with elemental silver.
- a method for producing a molded part from the composite material described herein comprises the following steps:
- step B) Application of a thin layer of the powder or the powder mixture from step A) to a construction platform;
- step B) sintering of the applied thin layer according to step B) by means of a laser
- step E1 dipping the shaped part according to step D) into molten elemental silver under vacuum conditions until the pores are filled with elemental silver
- step E2) Removal of the molding according to step E1) from the liquid silver and cooling to room temperature.
- the porosity of the molding according to step D) is preferably between 6% and 20%, more preferably between 8% and 15% and even more preferably between 10% and 12%.
- step E1) the pores of the molding according to step D) are completely filled with elemental silver.
- the method for producing a molded part from the composite material described herein comprises the following steps:
- step C) selectively applying a binder to the applied thin layer of step B);
- step D4 immersing the open-pored porous sintered body according to step D4) under reduced pressure conditions in molten elemental silver until the pores are filled with elemental silver, and
- step E2) Removal of the sintered part according to step E1) from the liquid silver and cooling to room temperature.
- the porosity of the molding according to step D4) is preferably between 6% and 20%, more preferably between 8% and 15% and even more preferably between 10% and 12%.
- step E1) the pores of the molding according to step D4) are preferably completely filled with elemental silver.
- the method for producing a molded part from the composite material described herein comprises the following steps:
- step B) Application of a thin layer of the powder or the powder mixture from step A) to a construction platform;
- step C) selectively applying a binder to the applied thin layer of step B);
- step E4) sintering of the molded part according to step E2) to form an open-pored sintered part with a porosity of 6% to 30% and expulsion of the binder, F1) dipping the sintered part according to step E4) into molten elemental silver under reduced pressure conditions until the pores are filled with elemental silver, and
- step F2) Removal of the sintered part according to step F1) from the liquid silver and cooling to room temperature.
- the porosity of the sintered compact according to step E4) is preferably between 6% and 20%, more preferably between 8% and 15% and even more preferably between 10% and 12%.
- step F1 the pores of the sintered body are preferably completely filled with elemental silver in accordance with step E4).
- the infiltration with elementary silver can also be carried out by separating silver from an aqueous solution containing silver ions (silver bath), through which electric current is passed by means of two electrodes (cathode and anode). Elemental silver then infiltrates into the pores of the sinter when it is in contact with the cathode.
- a further embodiment of the present invention relates to a method for producing the composite material described herein, comprising the following steps:
- step B producing a sintered blank from the granular powder or from the granular powder mixture of the matrix material from step A);
- step B) sintering of the sintered blank according to step B) below the melting temperature of the matrix material to form an open-pored sintered body with a porosity of 6% to 30%;
- step D′1 immersing the open-pore porous sintered body according to step C) in a silver bath and galvanically depositing elemental silver until the pores are at least partially filled with elemental silver;
- step D'2) Removal of the sintered part according to step D'1) from the silver bath.
- the method for preparing the composite material described herein comprises the following steps: A) Provision of a granular powder or a granular powder mixture of the matrix material;
- step B pressing a sintered blank from the granular powder or from the granular powder mixture of the matrix material from step A);
- step B) sintering of the sintered blank according to step B) with or without application of pressure by heat treatment below the melting temperature of the matrix material to form an open-pored sintered compact with a porosity of 6% to 30%;
- step D′1 immersing the open-pore porous sintered body according to step C) in a silver bath and galvanically depositing elemental silver until the pores are at least partially filled with elemental silver;
- step D'2) Removal of the sintered part according to step D'1) from the silver bath.
- the porosity according to step C) is preferably between 6% and 20%, more preferably between 8% and 15% and even more preferably between 10% and
- the sintered blank is already provided in the desired shape
- step D′1 the pores of the open-pore porous sintered compact according to step C) are preferably completely filled with elemental silver.
- step B) Application of a thin layer of the powder or the powder mixture from step A) to a construction platform;
- step B) sintering of the applied thin layer according to step B) by means of a laser
- step E1) immersing the shaped part according to step D) in a silver bath and galvanically depositing elemental silver until the pores are at least partially filled with elemental silver;
- step E2) removal of the molding according to step E1) from the silver bath.
- the porosity of the molding according to step D) is preferably between 6% and 20%, more preferably between 8% and 15% and even more preferably between 10% and 12%.
- the pores of the molding according to step D) are completely filled with elemental silver.
- the method for producing a molded part from the composite material described herein comprises the following steps:
- step B) Application of a thin layer of the powder or the powder mixture from step A) to a construction platform;
- step C) selectively applying a binder to the applied thin layer of step B);
- step E1 immersing the open-pored porous sintered body according to step D4) in a silver bath and galvanically depositing elemental silver until the pores are at least partially filled with elemental silver; and E2) removal of the molding according to step E1) from the silver bath.
- the porosity of the molding according to step D4) is preferably between 6% and 20%, more preferably between 8% and 15% and even more preferably between 10% and 12%.
- step E1) the pores of the molding according to step D4) are preferably completely filled with elemental silver.
- the method for producing a molded part from the composite material described herein comprises the following steps:
- step B) Application of a thin layer of the powder or the powder mixture from step A) to a construction platform;
- step B) selectively applying a binder to the applied thin layer of step B); D1) repeating steps B) and C) until the molded part has been obtained from the composite material,
- step D4 sintering of the molded part according to step D3) to form an open-pored porous sintered part with a porosity of 6% to 30% and expulsion of the binder,
- step E1) immersing the sintered part according to step D4) in a silver bath and galvanically depositing elemental silver until the pores are at least partially filled with elemental silver; and E2) removing the sintered part according to step E1) from the silver bath.
- the porosity of the sintered compact according to step D4) is preferably between 6% and 20%, more preferably between 8% and 15% and even more preferably between 10% and 12%.
- step E1 the pores of the sintered compact according to step D4) are preferably completely filled with elemental silver.
- the composite material according to the invention with silver infiltration should preferably be used in orthodontics for braces brackets. Due to the high-strength matrix material, the silver-infiltrated composite material withstands the high abrasive loads in the oral cavity. Surprisingly, the silver in the pores exhibits such a great antibacterial “remote action” that there is very little to no adhesion of a biofilm, even if the silver does not cover the entire surface like a coating. This was clearly demonstrated in a clinical study, as explained below.
- the present invention thus preferably relates to dentistry and is intended to reduce or prevent the accumulation of bacteria on surfaces located intraorally (in the oral cavity).
- a composite material with infiltrated silver was developed for this purpose.
- the metal or ceramic matrix material ensures abrasion resistance and the infiltrated silver provides the antibacterial effect.
- the formation of a biofilm and the associated negative consequences for the teeth, the periodontium and other collateral diseases are avoided.
- the antibacterial effect of the composite material according to the invention was demonstrated in the field of orthodontics on bracket material for braces.
- the otherwise resulting three-dimensional biofilm structure of bacteria, embedded in a matrix of extracellular polysaccharides, is prevented as soon as the fixed appliance is inserted.
- the bacteria that normally metabolize the supplied carbohydrates into organic acids and thereby create an acidic anaerobic environment are not present.
- no calcium and phosphate ions are released from the crystal lattice structure of the tooth enamel.
- the present invention prevents the initial stage of a carious lesion of the tooth.
- no whitish irreversible decalcification of the enamel is clinically visible.
- the invention on which it is based satisfies the need to carry out gentle orthodontic treatment using preventive treatment concepts as part of increasing health awareness and as a result of clinical necessity.
- the bracket material also withstands the highly abrasive loads to which orthodontic appliances are exposed as a result of shearing forces in the oral cavity.
- the composite material developed for e.g. brackets of dental braces itself has antibacterial properties according to the invention.
- the brackets made of the composite material according to the invention withstand the strong shearing forces in the oral cavity caused by the tongue and cheek.
- the antibacterial protective effect is permanent. The regular orthodontic treatment time for a fixed therapy is approx. 18 - 24 months. For this entire period, an antibacterial effect to prevent "white spot lesions" has been demonstrated by the composite material.
- the investigations of the abrasion behavior have shown that the biofilm formation is significantly reduced over the entire therapy period.
- the composite material with infiltrated silver withstands the shear forces acting in the oral cavity. Even if the matrix material wears off during long-term use in the oral cavity, the silver infiltration in the base material means that there is always enough silver on the pore surface to ensure the antibacterial effect. This is also the clear advantage over the conventional antibacterial coatings, which do not withstand the abrasive load for long, so that an initially clear antibacterial effect is lost quite quickly.
- the infiltration and homogeneous distribution of the silver in the matrix material and thus in the composite material guarantees a consistently good and, above all, long-lasting antibacterial effect even in the case of heavy abrasion.
- the present invention relates to medical implants which contain the composite material according to the invention or consist of the composite material.
- the medical implants described herein which consist of the composite material or the medical implants described herein which contain the composite material or components made of the composite material are particularly suitable for being subjected to shear forces and abrasion forces.
- These medical implants can be short-term medical implants or long-term medical implants and preferably long-term dental implants.
- anchoring devices such as transpalatal arches and lingual arches, which should also consist of antibacterial materials.
- mini-screws which are fixed for anchoring with the threads in the jawbone while the screw head remains exposed in the oral cavity, are an important area of application of the present invention.
- Ceramic tooth inlays and metallic or ceramic tooth crowns are another area of application for the composite material.
- examples of medical implants are in particular dental implants of all kinds such as brackets, orthodontic arches, ligatures and bands, dental anchorage devices such as transpalatal arches and lingual arches, temporary anchorage devices (e.g. minipins, palatal implants, bollard pins), mini screws, dental inlays and metal or ceramic ones ready-made dental crowns.
- dental implants of all kinds such as brackets, orthodontic arches, ligatures and bands, dental anchorage devices such as transpalatal arches and lingual arches, temporary anchorage devices (e.g. minipins, palatal implants, bollard pins), mini screws, dental inlays and metal or ceramic ones ready-made dental crowns.
- Dental implants such as brackets, transpalatal arches, lingual arches, mini-screws, dental inlays and metal or ceramic dental crowns can be made entirely of the composite material or contain only certain areas that have been made of the composite material. In the case of braces as a dental implant, only the brackets are usually made of the composite material.
- the composite material disclosed herein is preferably used for dental implants, other medical products and, above all, other implants that are also exposed to strong forces or pressures can also be manufactured from it.
- the composite material with infiltrated silver can be used as an implant material in orthopedics to prevent inflammation in knee implants, for example.
- other medical products are orthopedic implants such as joint implants, especially knee implants, intervertebral implants, bone wedges or bone screws.
- the great advantage of the composite material according to the invention is that this composite material is antibacterial per se and thus an antibacterial coating is unnecessary and thus also a further work step of applying an antibacterial coating to the medical implant or parts thereof.
- the present invention is the result of extensive biofilm research. None of the previous materials or material or surface modifications have shown satisfactory long-term antibacterial effects in numerous clinical studies. On the other hand, the composite material with silver infiltration has a strong long-term antibacterial effect and thus prevents or completely prevents the formation of a biofilm. Surprisingly, a closed silver surface is not required as with a coating to comprehensively reduce or prevent biofilm. Even composite materials with a silver content of less than 20%, whose interstices are filled with silver, show an excellent long-term antibacterial effect.
- the present invention has pursued a novel approach to effectively reduce the formation of biofilms, e.g. on orthodontic fixed appliances, and to produce a long-term antibacterial effect.
- the composite material with infiltrated silver developed according to the invention, it could be demonstrated that even with silver contents of less than 20%, preferably less than 15%, there are strong antibacterial properties, with silver contents of less than 10%, but a minimum silver content of 6%, there are still sufficient antibacterial properties and these antibacterial property persists even under abrasive conditions.
- the composite material is biocompatible.
- the composite material according to the invention differs significantly from the previous bracket materials on the market. Due to its inherent antibacterial effect, additional antibacterial coatings on the brackets are not necessary.
- the present invention thus combines antibacterial properties with long-lasting antibacterial protection to prevent an intraoral biofilm for the first time.
- FIG. 1 shows a scanning electron micrograph of a cross section of a porous matrix material (here tungsten) with infiltrated, homogeneously distributed silver (black).
- FIG. 2 shows a tooth cleaning machine for determining the abrasion resistance of brackets made of conventional stainless steel and of tungsten with infiltrated, homogeneously distributed silver.
- Example 1 Production of the Composite Material According to FIG. 1
- various fine-grain fractions of tungsten powder (different grain sizes) were combined and mixed over a longer period of time in order to obtain a uniform distribution of the grain sizes in the powder.
- the powder mixture was pressed in tools under high pressure to form so-called "green compacts".
- the green compacts already have the shape of the end product.
- thin discs with a diameter of 20 mm and a wall thickness of 2 mm were produced.
- the blanks (green compacts) were then sintered, i.e. "baked" at high temperatures, which are below the melting temperatures of tungsten here.
- the sintering process takes place in a protective gas atmosphere or in a vacuum.
- the finished sinters were then immersed in liquid silver. This is done in a vacuum so that all pores are completely filled with silver.
- the silver-containing discs were ground down on both sides to a wall thickness of 0.6 mm and cut to the outer dimensions of the brackets using a laser.
- Example 2 Scanning electron microscope image according to FIG. 1
- the brackets were attached to a sample holder and placed in the sample chamber of the scanning electron microscope from TESCAN, type Vega3—without further sample preparation.
- the recording of the sintered structure was created using the so-called BSE method (backscattered electrons), which enables a good material contrast.
- BSE method backscattered electrons
- the light areas represent the tungsten grains surrounded by dark (black) silver.
- Example 3 Abrasion Tests on a Silver-Infiltrated Composite Material
- endurance tests were carried out with a tooth cleaning machine on samples made from conventional stainless steel brackets and, for comparison, from a silver-infiltrated composite metal made from silver-infiltrated tungsten (see FIG. 2).
- the tooth brushing process was simulated for a period of 2 years with rotating toothbrushes, an oscillating linear relative movement between toothbrush and metal surface and the addition of abrasive toothpaste.
- the material removal of less than 50 ⁇ m in the bracket wall thickness is acceptable for a wearing period of 2 years.
- the brackets made of composite material are therefore sufficiently resistant to abrasion.
- the decisive factor is that with each removal, the silver in the pores is exposed, i.e. it is present on the bracket surface and ensures a permanent antibacterial effect.
- Example 4 Clinical study to prove the antibacterial effect of brackets
- carrier splints were worn intraorally, which were fitted with brackets made of conventional stainless steel and, in comparison, made of composite metal (here tungsten) with silver infiltration.
- the new composite material made of tungsten with a silver infiltration that was produced for the study was initially available in discs with a diameter of 19.3 mm and a thickness of 2.0 mm. Using a belt grinder, the blanks were reduced to an average wall thickness of 0.64 mm. The samples were then cut to an edge length of 5.0 x 5.0 mm using a laser.
- Test specimens made from conventionally available stainless steel bracket material with material number 1.4456 were used as a control group and cut to the same specimen size.
- Bonded metal specimens and the control specimen were determined using energy dispersive X-ray spectroscopy (EDX).
- EDX energy dispersive X-ray spectroscopy
- a toothbrushing machine was designed and built to simulate the abrasive stress on the brackets caused by daily brushing. It was assumed that the brackets were cleaned twice a day for two minutes each time with an average wearing time of 24 months. This period could be reproduced using the designed toothbrushing machine by continuously treating the samples for two hours.
- the study design created the same starting conditions as possible. Twelve healthy volunteers (six women and six men) aged between 21 and 30 years were included in the clinical study. All twelve subjects could be included in the study in compliance with the test protocol created. By means of a periodontal screening of the twelve subjects, it was verified that the study was being carried out under periodontally healthy oral conditions. Various periodontal indices, including the approximal plaque index as an indicator of the prevailing oral hygiene, were collected. Other risk criteria that change the composition of the microbial flora were excluded. These include pregnancy, smoking, general illnesses, removable dentures and the possible use of antibiotics in the last six weeks before the start of the study.
- a plastic mini-splint was manufactured using a deep-drawing process.
- plastic pads were attached to the miniplast splint in the posterior region. These pads were attached to a retaining wire at a small distance from the miniplast splint using the spray and scatter method, so that saliva circulation between the splint and the holding pad was perfectly possible.
- the rails were then fitted with the test specimens to be examined.
- the adhesive points on the splints were roughened using sandpaper.
- a wearing time of 48 hours was determined in several preliminary tests on test persons. During this time, oral hygiene and alcohol consumption had to be suspended in order not to provoke falsification of the biofilm formed by cleaning the test specimens. For eating, the splints were removed for a maximum of 40 minutes and stored in a humid environment.
- the splints were removed from the subjects and the biofilm formed was marked with a live/dead fluorescent stain and fixed with glutaraldehyde.
- the three-dimensional quantitative analysis of the fluorescence-stained biofilm was performed using confocal laser scanning microscopy (CLSM).
- CLSM confocal laser scanning microscopy
- bracket samples made of the silver-infiltrated tungsten composite metal showed a significantly reduced biofilm volume compared to the conventional stainless steel bracket material: a) For untreated bracket samples, the biofilm volume for the standard brackets made of stainless steel is 1,000,000 pm 3 on average and for the brackets made of silver-infiltrated composite metal on average only 280,000 pm 3 for LowAg and 120,000 pm 3 for HighAg (see Fig. 3).
- the average biofilm volume for the standard brackets made of stainless steel is 1,600,000 pm 3 and for the brackets made of silver-infiltrated composite metal on average only ⁇ 420,000 pm 3 for LowAg or 230,000 pm 3 for HighAg (see Figure 4).
- Fig. 4 shows that even with bracket material samples that were previously exposed to abrasion in the toothbrush machine (see Fig. 2), there is a significant reduction in the biofilm volume, ie the effect of the silver infiltrated in the matrix material is permanently retained despite abrasion of the edge layer.
- the antibacterial effect of the silver in the composite material is clearly shown when the biofilm, consisting of a large number of bacteria, is fluorescently stained after the intraoral wearing time and then evaluated under a confocal laser scanning microscope. 5 shows live bacteria in light and dead bacteria in dark.
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Ceramic Engineering (AREA)
- Manufacturing & Machinery (AREA)
- Mechanical Engineering (AREA)
- Metallurgy (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Structural Engineering (AREA)
- Life Sciences & Earth Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Inorganic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Physics & Mathematics (AREA)
- Cardiology (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Plastic & Reconstructive Surgery (AREA)
- Plasma & Fusion (AREA)
- Powder Metallurgy (AREA)
- Dental Preparations (AREA)
Abstract
La présente invention concerne un matériau composite constitué d'un matériau de matrice fritté poreux à pores ouverts et d'argent élémentaire, l'argent élémentaire étant infiltré dans les pores du matériau de matrice fritté poreux à pores ouverts, la teneur en argent dans le matériau composite étant comprise entre 6 % en poids et 30 % en poids et le matériau de matrice poreux à pores ouverts étant constitué d'au moins un métal, d'au moins un alliage métallique ou d'au moins une céramique, l'invention concernant également des procédés de fabrication de ce matériau composite et des implants médicaux contenant ce matériau composite. Le matériau composite est particulièrement approprié pour réduire et éviter la formation de biofilm.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP21164744.1A EP4063042A1 (fr) | 2021-03-24 | 2021-03-24 | Matière composite à intégration de l'argent en tant que matière matricielle antibactérienne en particulier destinée à la réduction de biofilm |
PCT/EP2022/057631 WO2022200429A1 (fr) | 2021-03-24 | 2022-03-23 | Matériau composite comprenant une infiltration d'argent en tant que matériau de matrice antibactérien, en particulier pour la réduction de biofilm |
Publications (1)
Publication Number | Publication Date |
---|---|
EP4313448A1 true EP4313448A1 (fr) | 2024-02-07 |
Family
ID=75223097
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP21164744.1A Withdrawn EP4063042A1 (fr) | 2021-03-24 | 2021-03-24 | Matière composite à intégration de l'argent en tant que matière matricielle antibactérienne en particulier destinée à la réduction de biofilm |
EP22717168.3A Pending EP4313448A1 (fr) | 2021-03-24 | 2022-03-23 | Matériau composite comprenant une infiltration d'argent en tant que matériau de matrice antibactérien, en particulier pour la réduction de biofilm |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP21164744.1A Withdrawn EP4063042A1 (fr) | 2021-03-24 | 2021-03-24 | Matière composite à intégration de l'argent en tant que matière matricielle antibactérienne en particulier destinée à la réduction de biofilm |
Country Status (2)
Country | Link |
---|---|
EP (2) | EP4063042A1 (fr) |
WO (1) | WO2022200429A1 (fr) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3310427A (en) * | 1963-01-29 | 1967-03-21 | Sylvania Electric Prod | Method and apparatus for infiltrating porous bodies |
DE2357333C3 (de) * | 1973-11-16 | 1980-04-03 | Siemens Ag, 1000 Berlin Und 8000 Muenchen | Durchdringungsverbundmetall als Kontaktwerkstoff für Vakuumschalter |
US20030217828A1 (en) * | 2002-05-22 | 2003-11-27 | Mark Opoku-Adusei | Metal matrix composite having improved microstructure and the process for making the same |
CN102648876B (zh) * | 2011-02-24 | 2015-08-26 | 北京圣玛特科技有限公司 | 抗菌牙齿矫形丝及其制造方法 |
CN111197130A (zh) * | 2019-12-20 | 2020-05-26 | 南通金源智能技术有限公司 | 一种牙科活动修复用3d打印金属粉末及其制备方法 |
-
2021
- 2021-03-24 EP EP21164744.1A patent/EP4063042A1/fr not_active Withdrawn
-
2022
- 2022-03-23 WO PCT/EP2022/057631 patent/WO2022200429A1/fr active Application Filing
- 2022-03-23 EP EP22717168.3A patent/EP4313448A1/fr active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2022200429A1 (fr) | 2022-09-29 |
EP4063042A1 (fr) | 2022-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0225279B1 (fr) | Vitrocéramique de mica-cordiérite | |
EP0006544B1 (fr) | Matériau de remplacement des os pour implantation à base de céramique de phosphate de calcium dans une matrice et procédé pour sa fabrication | |
DD281749A5 (de) | Implantat fuer den ersatz eines zahnes oder ausserhalb des knochengewebes | |
EP0193588B1 (fr) | Materiau contenant de l'apatite de carbonate, et utilisaton de l'apatite de carbonate pour effectuer des implants | |
Juntavee et al. | Remineralization potential of nano-hydroxyapatite on enamel and cementum surrounding margin of computer-aided design and computer-aided manufacturing ceramic restoration | |
DE3905608C2 (fr) | ||
EP0576500B1 (fr) | Appareil orthodontique auxiliaire | |
DE2733394B2 (de) | Kunstzahn mit implantierbarer Zahnwurzel | |
DE4311319A1 (de) | Zahnbracket | |
EP1450722A1 (fr) | Implant dentaire c ramique | |
Zhong et al. | Clinical evaluation of a new technique for interdental enamel reduction | |
DE2759214A1 (de) | Verfahren zur herstellung von implantaten | |
EP0319717A1 (fr) | Pivot radiculaire | |
DE102006047054A1 (de) | Patientenindividuelles Implantatlager | |
DE68915265T2 (de) | Ärztliches und zahnärztliches vernetzbares material. | |
EP3253326B1 (fr) | Revêtement de surfaces prothétiques dentaires, présentant une couche spécifique d'une hydroxyapatite de synthèse | |
DE4039248A1 (de) | Enossales zahnimplantat | |
Suhag et al. | Root end filling materials: A review | |
EP4313448A1 (fr) | Matériau composite comprenant une infiltration d'argent en tant que matériau de matrice antibactérien, en particulier pour la réduction de biofilm | |
DE2401323A1 (de) | Implantat fuer zahnprothesen | |
DE3935060C2 (de) | Verfahren zur Herstellung eines keramischen Materials für den Dentalbereich und eine Verwendung desselben | |
EP1824443B1 (fr) | Matiere premiere d'hydroxylapatite et procede pour la produire | |
DE3328905A1 (de) | Zahnprothese und verfahren fuer ihre herstellung | |
DE102004049140B4 (de) | Werkstück und Verfahren zur Herstellung eines chirurgischen Implantats oder eines künstlichen Zahnmaterials | |
EP4197486B1 (fr) | Blanc et procédé de préparation d'un tel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20230919 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) |